Floatz logo

154 assets in Colon Carcinoma

Therapeutic assets addressing Colon Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Colon Carcinoma
City of Hope Medical CenterP1CC (46)
Pegylated Interferon-Alpha-2A
Colon Carcinoma
Zealand University HospitalP2CC (45)
e-602
Colon Carcinoma
Palleon Pharmaceuticals, Inc.P1/2CC (44)
TIL
Colon Carcinoma
Essen BiotechP1/2CC (44)
Ceralasertib
Colon Carcinoma
National Cancer Institute (NCI)P1CC (43)
Trastuzumab Deruxtecan
Colon Carcinoma
National Cancer Institute (NCI)P1CC (43)
1.0% ip-001 for
Colon Carcinoma
Immunophotonics, Inc.P1/2CC (41)
a2b395
Colon Carcinoma
A2 Biotherapeutics Inc.P1/2CC (41)
a2b543
Colon Carcinoma
A2 Biotherapeutics Inc.P1/2CC (41)
a2b694
Colon Carcinoma
A2 Biotherapeutics Inc.P1/2CC (41)
Anti-Kras G12V Mtcr Pbl
Colon Carcinoma
National Cancer Institute (NCI)P1/2CC (41)
gsk4418959
Colon Carcinoma
GlaxoSmithKlineP1/2CC (41)
mdx2001
Colon Carcinoma
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (41)
pds01adc
Colon Carcinoma
National Cancer Institute (NCI)P1/2CC (41)
Ropidoxuridine
Colon Carcinoma
National Cancer Institute (NCI)P1CC (41)
Selpercatinib
Colon Carcinoma
Eli Lilly and CompanyP1/2CC (41)
Solnerstotug
Colon Carcinoma
Sensei Biotherapeutics, Inc.P1/2CC (41)
Expanded Cb-Nk Cells
Colon Carcinoma
M.D. Anderson Cancer CenterP1CC (40)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap
Colon Carcinoma
National Cancer Institute (NCI)P1/2CC (40)
89zr-dfo-n-suc-c9scfv
Colon Carcinoma
Var2 PharmaceuticalsEarly P1C (39)
89Zr-DFO-N-Suc-F8scFv
Colon Carcinoma
Var2 PharmaceuticalsEarly P1C (39)
Certepetide
Colon Carcinoma
Anup KasiP1/2C (39)
Delta-8-Tetrahydrocannabinol
Colon Carcinoma
City of Hope Medical CenterEarly P1C (39)
²¹²pb-dotam-grpr1
Colon Carcinoma
Orano Med Theranostics, SASP1C (37)
Adagrasib
Colon Carcinoma
M.D. Anderson Cancer CenterP1C (37)
Atx-559
Colon Carcinoma
Accent TherapeuticsP1C (37)
aur106
Colon Carcinoma
Aurigene Discovery Technologies LimitedP1C (37)
Brodalumab
Colon Carcinoma
Brian Henick, MDP1C (37)
Cbi-1214
Colon Carcinoma
Cartography BiosciencesP1C (37)
Cea Car-T Cells
Colon Carcinoma
Chongqing Precision Biotech Co., LtdP1C (37)
Hbi-2438
Colon Carcinoma
HUYABIO International, LLC.P1C (37)
Phn-010
Colon Carcinoma
Pheon TherapeuticsP1C (37)
Phn-012
Colon Carcinoma
Pheon TherapeuticsP1C (37)
Rsc-1255
Colon Carcinoma
RasCal Therapeutics, Inc.P1C (37)
st316
Colon Carcinoma
Sapience TherapeuticsP1C (37)
Vitamin D
Colon Carcinoma
M.D. Anderson Cancer CenterEarly P1C (37)
kt032
Colon Carcinoma
Weijia Fang, MDEarly P1C (34)
[18f]f-resca-g5
Colon Carcinoma
RenJi HospitalN/AD (28)
[18f]f-resca-rb14
Colon Carcinoma
RenJi HospitalN/AD (28)
[18F]F-RESCA-RND20
Colon Carcinoma
RenJi HospitalN/AD (28)
[18F]F-RESCA-T4
Colon Carcinoma
RenJi HospitalN/AD (28)
[18f]f-resca-wwh347
Colon Carcinoma
RenJi HospitalN/AD (28)
[68Ga]Ga-DOTA-H2D3
Colon Carcinoma
RenJi HospitalN/AD (28)
[68ga]ga-nota-g5
Colon Carcinoma
RenJi HospitalN/AD (28)
[68ga]ga-nota-rnd20
Colon Carcinoma
RenJi HospitalN/AD (28)
[68ga]ga-nota-t4
Colon Carcinoma
RenJi HospitalN/AD (28)
[68Ga]Ga-NOTA-WWH347
Colon Carcinoma
RenJi HospitalN/AD (28)
Copper Cu 64 Anti-Cea Monoclonal Antibody M5A
Colon Carcinoma
City of Hope Medical CenterN/AD (28)
Showing 101 to 150 of 154 assets
PreviousPage 3 of 4Next